Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             78 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 1.317 A case that has been diagnosed as cirrhosis after the emergence of parkinsonism symptoms Turkmen, C.
2007
13 Supplement 2 p. S81-
1 p.
artikel
2 3.403 Activity and participation on Parkinson's disease Nickel, R.
2007
13 Supplement 2 p. S180-S181
2 p.
artikel
3 2.257 A double blind placebo controlled study of modafinil for Parkinson's disease related fatigue Tyne, H.
2007
13 Supplement 2 p. S113-S114
2 p.
artikel
4 1.120 Advanced screening tools in day-to-day movement disorders observed in ambulatory assistance Echebarria, S.G.
2007
13 Supplement 2 p. S38-S39
2 p.
artikel
5 2.438 A neuroprotective role for cerebrolysin in a rotenone model of Parkinson's disease Stoica, R.
2007
13 Supplement 2 p. S137-S138
2 p.
artikel
6 Aprataxin (APTX) gene mutations resembling multiple system atrophy Baba, Yasuhiko
2007
13 Supplement 2 p. 139-142
4 p.
artikel
7 Association of α-synuclein gene haplotypes with Parkinson's disease Parsian, A.J.
2007
13 Supplement 2 p. 343-347
5 p.
artikel
8 1.157 Body mass index is reduced in Parkinson's disease Adwan, Z.
2007
13 Supplement 2 p. S48-
1 p.
artikel
9 1.144 Changes in sexual interest and function in patients with Parkinson's disease: Focus on hypersexuality Naidu, Y.
2007
13 Supplement 2 p. S44-S45
2 p.
artikel
10 2.407 Characterization of lentiviral vector mediated gene transfer and expression in organotypic ventral mesencephalic cultures from foetal mice Rossen, S.
2007
13 Supplement 2 p. S129-
1 p.
artikel
11 1.283 Clinical and genetic study of a large Dutch family with autosomal dominant restless legs syndrome Bakker, S.
2007
13 Supplement 2 p. S72-
1 p.
artikel
12 Clinical characteristics of corticobasal syndrome amongst Chinese in Taiwan Chang, Kuo-Hsuan
2007
13 Supplement 2 p. 219-223
5 p.
artikel
13 1.314 Clinical characteristics of 49 patients with psychogenic movement disorders in a tertiary clinic in Turkey Ozekmekci, S.
2007
13 Supplement 2 p. S80-
1 p.
artikel
14 1.300 Cognitive impairments as diagnostic markers for ADHD: An overview Gupta, R.
2007
13 Supplement 2 p. S76-
1 p.
artikel
15 3.108 Combined [123I]FP-CIT SPECT and 99mTc-HMPAO SPECT for the diagnosis of dementia with Lewy bodies Mendonça Silva, N.M.
2007
13 Supplement 2 p. S155-
1 p.
artikel
16 2.227 Continuous dopaminergic stimulation in Parkinson's disease: Comparison of new methods of drug delivery by measuring dopamine metabolites concentrations in plasma Saurugg, R.
2007
13 Supplement 2 p. S105-
1 p.
artikel
17 1.174 Correlation between severity of Parkinson's disease (according to Hoehn–Yahr) and depression in Parkinson's disease (Hamilton Depression Rating Scale) Sani, A.F.
2007
13 Supplement 2 p. S53-
1 p.
artikel
18 Developing a PD Service Baker, Mary G.
2007
13 Supplement 2 p. S498-S500
3 p.
artikel
19 3.420 Differential effect of the Parkinson's disease non-motor symptoms on patients' health-related quality of life Naidu, Y.
2007
13 Supplement 2 p. S185-
1 p.
artikel
20 3.212 Distinct psychosocial profiles remain stable over time in patients with Parkinson's disease undergoing DBS-STN Kaiser, I.
2007
13 Supplement 2 p. S165-
1 p.
artikel
21 1.011 Early diagnosis for Parkinson's disease according to whole blood gene profile Grünblatt, E.
2007
13 Supplement 2 p. S30-
1 p.
artikel
22 2.244 Efficacy of rotigotine transdermal patch as adjunct to levodopa in subgroups of advanced-stage Parkinson's patients LeWitt, P.
2007
13 Supplement 2 p. S110-
1 p.
artikel
23 3.003 Epidemiology Breteler, M.
2007
13 Supplement 2 p. S147-
1 p.
artikel
24 3.209 Extension wire tethering: A late post operative complication for deep brain stimulation Moore, H.J.
2007
13 Supplement 2 p. S164-
1 p.
artikel
25 2.315 Identification of potent small molecule inhibitors of alpha-synuclein aggregation in cell culture and by in vitro screening Snow, A.
2007
13 Supplement 2 p. S125-
1 p.
artikel
26 Impact of physical therapy for Parkinson's disease: A critical review of the literature Kwakkel, G.
2007
13 Supplement 2 p. S478-S487
10 p.
artikel
27 2.213 Improved antiparkinsonian effects during the night with levodopa/dopa decarboxylase inhibitor and entacapone compared with levodopa/dopa decarboxylase inhibitor in Parkinson's disease patients experiencing symptom re-emergence due to wearing-off Nissinen, H.
2007
13 Supplement 2 p. S101-
1 p.
artikel
28 2.IS.3.3 Deep brain stimulation or Duodopa: Choosing the right therapy for individual patients Volkmann, J.
2007
13 Supplement 2 p. S146-
1 p.
artikel
29 2.410 Is H5N1 influenza virus a novel etiological agent in the development of post-encephalitic parkinsonism? Smeyne, R.
2007
13 Supplement 2 p. S130-
1 p.
artikel
30 2.118 Lack of association between genetic polymorphism of angiotensin-converting enzyme and Parkinson's disease Meco, G.
2007
13 Supplement 2 p. S96-S97
2 p.
artikel
31 L-DOPA-induced dyskinesia: cellular mechanisms and approaches to treatment Cenci, M. Angela
2007
13 Supplement 2 p. S263-S267
5 p.
artikel
32 3.241 Localization of spontaneous thalamic local field potential activity recorded during stereotactic functional neurosurgery Kempf, F.
2007
13 Supplement 2 p. S173-
1 p.
artikel
33 3.243 Low-frequency repetitive transcranial magnetic stimulation (rTMS) reduces levodopa induced diphasic dyskinesias in Parkinson's disease (PD): A case report Filipovic, S.
2007
13 Supplement 2 p. S173-S174
2 p.
artikel
34 Lrrk2 G2385R is an ancestral risk factor for Parkinson's disease in Asia Farrer, Matthew J.
2007
13 Supplement 2 p. 89-92
4 p.
artikel
35 LRRK2 mutations and Parkinson's disease in Sardinia—A Mediterranean genetic isolate Cossu, Giovanni
2007
13 Supplement 2 p. 17-21
5 p.
artikel
36 1.117 Mistakes at the beginning of Parkinson disease: Report of clinical cases Pavlic, G.
2007
13 Supplement 2 p. S38-
1 p.
artikel
37 2.015 Molecular mechanism of L-Dopa induced dyskinesia in Parkinson's disease Subhani, F.U.-H.
2007
13 Supplement 2 p. S89-S90
2 p.
artikel
38 1.207 Mortality in a community based cohort of Parkinson's disease patients with and without dementia in a rural area of North Wales in the United Kingdom Hobson, P.
2007
13 Supplement 2 p. S62-
1 p.
artikel
39 Myoclonus Caviness, John N.
2007
13 Supplement 2 p. S375-S384
10 p.
artikel
40 2.441 Nicotine provides protective effects in dopaminergic neurons via the nicotinic receptors Takeuchi, H.
2007
13 Supplement 2 p. S138-
1 p.
artikel
41 Nitrous oxide promotes hyperhomocysteinemia in levodopa treated rats Henninger, Nils
2007
13 Supplement 2 p. 524-527
4 p.
artikel
42 1.014 Non-motor symptoms in akinesia dominant versus other phenotypes in Parkinson's disease (PD): Results from the international PD non-motor symptoms scale study Naidu, Y.
2007
13 Supplement 2 p. S31-
1 p.
artikel
43 2.274 Onset age or age for initial L-dopa treatment: Which is a more important risk factor for L-DOPA-induced dyskinesia in Parkinson's disease? Kimura, T.
2007
13 Supplement 2 p. S118-
1 p.
artikel
44 1.505 Pathophysiology of levodopa-induced dyskinesia in Parkinson's disease: Role of pre- and postsynaptic mechanisms Linazasoro, G.
2007
13 Supplement 2 p. S85-
1 p.
artikel
45 2.115 Perry's syndrome is a unique TDP-43 proteinopathy Wider, C.
2007
13 Supplement 2 p. S96-
1 p.
artikel
46 Physiology and pathophysiology of the basal ganglia—thalamo—cortical networks Rosin, Boris
2007
13 Supplement 2 p. S437-S439
3 p.
artikel
47 Polymorphisms of catechol-0-methyltransferase (COMT), monoamine oxidase B (MAOB), N-acetyltransferase 2 (NAT2) and cytochrome P450 2D6 (CYP2D6) gene in patients with early onset of Parkinson’s disease Bialecka, M.
2007
13 Supplement 2 p. 224-229
6 p.
artikel
48 Positron emission tomography in premotor Parkinson's disease Stoessl, A. Jon
2007
13 Supplement 2 p. S421-S424
4 p.
artikel
49 2.230 Pramipexole monotherapy in the treatment of early Parkinson's disease: Results of a 3 year follow up of a randomized controlled study Oztekin, N.
2007
13 Supplement 2 p. S106-
1 p.
artikel
50 3.507 Predictors of health-related quality of life in patients with Parkinson's disease Martinez-Martin, P.
2007
13 Supplement 2 p. S189-
1 p.
artikel
51 Prevalence of cervical dystonia and spasmodic torticollis in the United States general population Jankovic, J.
2007
13 Supplement 2 p. 411-416
6 p.
artikel
52 1.253 Primary lingual dystonia induced by speaking and improvement with singing: A similarity with stuttering Ozen, B.
2007
13 Supplement 2 p. S66-
1 p.
artikel
53 1.286 Restless legs syndrome in Korean patients with Parkinson disease Lee, J.E.
2007
13 Supplement 2 p. S72-
1 p.
artikel
54 1.204 Rivastigmin (Exelon) for non demented Parkinson patients with hallucinations: A single center experience under real life conditions Kohler, J.
2007
13 Supplement 2 p. S61-
1 p.
artikel
55 2.501 Role of DeltaFosB in the development of L-DOPA-induced dyskinesia in a non-human primate model of Parkinson's disease Bezard, E.
2007
13 Supplement 2 p. S142-
1 p.
artikel
56 1.160 Serum leptin and ghrelin concentrations in Parkinson's disease patients with and without weight loss Fiszer, U.
2007
13 Supplement 2 p. S49-
1 p.
artikel
57 1.323 Siblings of SCA type 2 with heterogenous neurodegenerative disorders Yabe, H.
2007
13 Supplement 2 p. S82-S83
2 p.
artikel
58 SPECT imaging, immunohistochemical and behavioural correlations in the primate models of Parkinson's disease Ashkan, Keyoumars
2007
13 Supplement 2 p. 266-275
10 p.
artikel
59 Surgery for Parkinson's disease improves disability but not impairment components of the UPDRS-II Haffenden, A.
2007
13 Supplement 2 p. 399-405
7 p.
artikel
60 3.018 Survival and host immune response of implants of human retinal pigment epithelial cells on gelatin microcarriers (hRPE-GM) (Spheramine®) in animal models of Parkinson's disease (PD) Flores, J.
2007
13 Supplement 2 p. S150-
1 p.
artikel
61 1.263 Symptoms accompanying hemifacial spasm Wojcik, M.
2007
13 Supplement 2 p. S68-
1 p.
artikel
62 Table of Contents 2007
13 Supplement 2 p. v-viii
nvt p.
artikel
63 2.260 TEAM: A French cross-sectional study on the time-related evolution of the scores of the “Handipark”, in relation to the duration of the Parkinson's disease Ziegler, M.
2007
13 Supplement 2 p. S114-
1 p.
artikel
64 3.417 The effects of pharmacological treatment on speech in Parkinson's disease Santens, P.
2007
13 Supplement 2 p. S184-
1 p.
artikel
65 3.226 The frequency and magnitude of impulse control deficits in Parkinson's disease patients with deep brain stimulation of the subthalamic nucleus Tse, W.
2007
13 Supplement 2 p. S168-S169
2 p.
artikel
66 2.104 The leucine rich repeat kinase 2 (LRRK2) G2019S substitution mutation: Association with Parkinson's disease and malignant melanoma Molchadski, I.
2007
13 Supplement 2 p. S93-
1 p.
artikel
67 2.014 The leucine rich repeat kinase 2 (LRRK2) G2019S substitution mutation: Association with Parkinson's disease and malignant melanoma Molchadski, I.
2007
13 Supplement 2 p. S89-
1 p.
artikel
68 The natural history of neurological manganism over 18 years Huang, C.-C.
2007
13 Supplement 2 p. 143-145
3 p.
artikel
69 1.191 The relationship between executive and motor functioning in patients with Parkinson's disease Olzak, M.
2007
13 Supplement 2 p. S57-
1 p.
artikel
70 3.309 The repeatability of standardised movement analysis of people with Parkinson's disease in the home and the gait lab Roberts, H.
2007
13 Supplement 2 p. S177-S178
2 p.
artikel
71 1.103 Toxic substance exposure and chracteristics of Parkinson's disease Budisic, M.
2007
13 Supplement 2 p. S34-
1 p.
artikel
72 3.126 Transcranial sonography and Parkinson disease Bolokadze, L.
2007
13 Supplement 2 p. S160-
1 p.
artikel
73 2.105 Transcriptome profiling in peripheral blood cells of LRRK2 G2019S mutation patients Mutez, E.
2007
13 Supplement 2 p. S93-
1 p.
artikel
74 Treatment of dystonia Adam, Octavian R.
2007
13 Supplement 2 p. S362-S368
7 p.
artikel
75 Unraveling progressive supranuclear palsy: from the bedsideback to the bench Houghton, David J.
2007
13 Supplement 2 p. S341-S346
6 p.
artikel
76 2.424 Variation of magnesium levels in RBC and extracelluar fluid of midbrain substantia nigra of rat model of Parkinson's disease Luo, Y.
2007
13 Supplement 2 p. S134-
1 p.
artikel
77 1.130 Visual electrophysiology in Parkinson's disease: Relation to clinical and functional impairments Osman Achmawi, G.A.
2007
13 Supplement 2 p. S41-
1 p.
artikel
78 1.256 Xeroderma Pigmentosum with neurological manifestations: 2 observations Thobois, S.
2007
13 Supplement 2 p. S66-S67
2 p.
artikel
                             78 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland